Junjun Chu

1.4k total citations
23 papers, 1.0k citations indexed

About

Junjun Chu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Junjun Chu has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Immunology. Recurrent topics in Junjun Chu's work include Immunotherapy and Immune Responses (5 papers), RNA modifications and cancer (4 papers) and CAR-T cell therapy research (3 papers). Junjun Chu is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), RNA modifications and cancer (4 papers) and CAR-T cell therapy research (3 papers). Junjun Chu collaborates with scholars based in China, United States and Australia. Junjun Chu's co-authors include Rong‐Fu Wang, Changsheng Xing, Helen Y. Wang, Wenyong Long, Qianquan Ma, Mei Luo, Qing Liu, Yinghua Zhu, Tianhao Duan and Bingnan Yin and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and JNCI Journal of the National Cancer Institute.

In The Last Decade

Junjun Chu

23 papers receiving 994 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junjun Chu China 16 608 312 256 190 90 23 1.0k
Jiang Ren China 21 772 1.3× 289 0.9× 499 1.9× 212 1.1× 130 1.4× 34 1.3k
Jodi M. Saunus Australia 22 641 1.1× 227 0.7× 430 1.7× 149 0.8× 237 2.6× 49 1.1k
Carmela Dell’Aversana Italy 20 937 1.5× 289 0.9× 172 0.7× 119 0.6× 89 1.0× 40 1.4k
Guang‐Hui Jin China 21 817 1.3× 190 0.6× 229 0.9× 219 1.2× 83 0.9× 46 1.3k
Hossein Safarpour Iran 20 549 0.9× 190 0.6× 372 1.5× 269 1.4× 122 1.4× 65 1.1k
Hai Hu China 18 666 1.1× 245 0.8× 551 2.2× 222 1.2× 190 2.1× 33 1.3k
Leonardo Josué Castro-Muñoz Mexico 10 485 0.8× 414 1.3× 204 0.8× 168 0.9× 92 1.0× 18 928
Mostafa Manian Iran 14 579 1.0× 395 1.3× 249 1.0× 141 0.7× 86 1.0× 26 1.1k
Zhuoran Zhang China 18 805 1.3× 611 2.0× 160 0.6× 243 1.3× 66 0.7× 36 1.2k

Countries citing papers authored by Junjun Chu

Since Specialization
Citations

This map shows the geographic impact of Junjun Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junjun Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junjun Chu more than expected).

Fields of papers citing papers by Junjun Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junjun Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junjun Chu. The network helps show where Junjun Chu may publish in the future.

Co-authorship network of co-authors of Junjun Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Junjun Chu. A scholar is included among the top collaborators of Junjun Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junjun Chu. Junjun Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duan, Tianhao, Yang Du, Changsheng Xing, et al.. (2023). USP3 plays a critical role in the induction of innate immune tolerance. EMBO Reports. 24(12). e57828–e57828. 7 indexed citations
2.
Du, Yang, Zhiqiang Hu, Jiansen Lu, et al.. (2022). Activation of cGAS‐STING by Lethal Malaria N67C Dictates Immunity and Mortality through Induction of CD11b+Ly6Chi Proinflammatory Monocytes. Advanced Science. 9(22). e2103701–e2103701. 11 indexed citations
3.
Xing, Changsheng, Yang Du, Tianhao Duan, et al.. (2022). Interaction between microbiota and immunity and its implication in colorectal cancer. Frontiers in Immunology. 13. 963819–963819. 27 indexed citations
4.
Yang, Zhen, Feng Li, Yuqian Huang, et al.. (2022). Dynamic Tumor-Specific MHC-II Immuno-PET Predicts Checkpoint Inhibitor Immunotherapy Efficacy in Melanoma. Journal of Nuclear Medicine. 63(11). jnumed.121.263151–jnumed.121.263151. 6 indexed citations
5.
Liu, Xin, Yixiang Xu, Wei Xiong, et al.. (2022). Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 10(3). e004035–e004035. 33 indexed citations
6.
Chu, Junjun, Changsheng Xing, Yang Du, et al.. (2021). Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication. Nature Metabolism. 3(11). 1466–1475. 88 indexed citations
7.
Ji, Xiujie, Chenyue Li, Junjun Chu, et al.. (2021). Nanoporous Carbon Aerogels for Laser-Printed Wearable Sensors. ACS Applied Nano Materials. 4(7). 6796–6804. 21 indexed citations
8.
Xing, Changsheng, Mingjun Wang, Peng Tan, et al.. (2021). Microbiota regulate innate immune signaling and protective immunity against cancer. Cell Host & Microbe. 29(6). 959–974.e7. 116 indexed citations
9.
Li, Qingtian, Jia Zou, Changsheng Xing, et al.. (2019). JMJD3 regulates CD4+ T cell trafficking by targeting actin cytoskeleton regulatory gene Pdlim4. Journal of Clinical Investigation. 129(11). 4745–4757. 14 indexed citations
10.
Luo, Man‐Li, Jingjing Li, Liping Shen, et al.. (2019). The Role of APAL/ST8SIA6-AS1 lncRNA in PLK1 Activation and Mitotic Catastrophe of Tumor Cells. JNCI Journal of the National Cancer Institute. 112(4). 356–368. 43 indexed citations
11.
Huang, Chen‐Song, Junjun Chu, Jianhui Li, et al.. (2018). The C/EBPβ-LINC01133 axis promotes cell proliferation in pancreatic ductal adenocarcinoma through upregulation of CCNG1. Cancer Letters. 421. 63–72. 51 indexed citations
12.
Zhu, Yinghua, Yujie Liu, Chao Zhang, et al.. (2018). Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1. Nature Communications. 9(1). 1595–1595. 110 indexed citations
13.
Tian, Xiao‐Peng, Juntao Wang, Xianhao Liu, et al.. (2018). Treatment of metastatic non‑small cell lung cancer with NY‑ESO‑1 specific TCR engineered‑T cells in a phase I clinical trial: A case report. Oncology Letters. 16(6). 6998–7007. 40 indexed citations
14.
Ma, Qianquan, Wenyong Long, Changsheng Xing, et al.. (2018). Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma. Frontiers in Immunology. 9. 2924–2924. 172 indexed citations
15.
Long, Wenyong, Wei Zhao, Bo Ning, et al.. (2018). PHF20 collaborates with PARP1 to promote stemness and aggressiveness of neuroblastoma cells through activation of SOX2 and OCT4. Journal of Molecular Cell Biology. 10(2). 147–160. 25 indexed citations
16.
Wu, Yanqing, Yinghua Zhu, Shunrong Li, et al.. (2017). Terrein performs antitumor functions on esophageal cancer cells by inhibiting cell proliferation and synergistic interaction with cisplatin. Oncology Letters. 13(4). 2805–2810. 15 indexed citations
17.
Mo, Jingxin, Xiaojia Huang, Bing Lu, et al.. (2017). Multifunctional nanoparticles for co-delivery of paclitaxel and carboplatin against ovarian cancer by inactivating the JMJD3-HER2 axis. Nanoscale. 9(35). 13142–13152. 42 indexed citations
18.
Chu, Junjun, Yanqing Wu, Lijuan Sun, et al.. (2015). NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2. Oncotarget. 6(32). 32410–32425. 78 indexed citations
19.
Lv, Xiaobin, Wei Wu, Xiaofeng Tang, et al.. (2015). Regulation of SOX10 stability via ubiquitination-mediated degradation by Fbxw7α modulates melanoma cell migration. Oncotarget. 6(34). 36370–36382. 19 indexed citations
20.
Hu, Zheng, et al.. (2009). [Models for risk assessment and prediction in breast cancer].. PubMed. 30(10). 1073–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiang Ren Breakdown of academic impact, for papers by Jodi M. Saunus Breakdown of academic impact, for papers by Carmela Dell’Aversana Breakdown of academic impact, for papers by Guang‐Hui Jin Breakdown of academic impact, for papers by Hossein Safarpour Breakdown of academic impact, for papers by Hai Hu Breakdown of academic impact, for papers by Leonardo Josué Castro-Muñoz Breakdown of academic impact, for papers by Mostafa Manian Breakdown of academic impact, for papers by Zhuoran Zhang
Rankless by CCL
2026